Peroxisome Proliferator-Activated Receptor Gamma (PPARγ; NR1C3)
| Product Family | Product Number | Product Description | Technical Manual |
| IB0010 PPARγ (NR1C3) |
IB00101-32 | Human PPARγ Reporter Assay System, 3 x 32 assays in 96-well format | Technical Manual |
| IB00101 | Human PPARγ Reporter Assay System, 1 x 96-well format assays | Technical Manual | |
| IB00102 | Human PPARγ Reporter Assay System, 1 x 384-well format assays | Technical Manual |
Also available in: Mouse/Rat Shared Ortholog, Cyn Monkey. Zebrafish
Peroxisome Proliferator-Activated Receptor Gamma (PPARγ), also known as the glitazone receptor, or NR1C3 is a type II nuclear receptor that in humans is encoded by the PPARγ gene. PPARs form heterodimers with Retinoid X Receptors (RXRs) and these heterodimers regulate transcription of various genes. PPARγ regulates adipocyte differentiation, fatty acid storage and glucose metabolism. The PPARγ knockout mice fail to generate adipose tissue when fed a high fat diet. Many insulin sensitizing drugs used in the treatment of diabetes target PPARγ as a means to lower serum glucose without increasing pancreatic insulin secretion. Additionally, PPARγ has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described.
INDIGO's PPARγ Reporter Assay System utilize proprietary mammalian cells engineered to express human PPARG, commonly referred to as PPARγ.
The principle application of this assay product is in the screening of test samples to quantify functional activities, either agonist or antagonist, that they may exert against the human peroxisome proliferator-activated receptor gamma.
For more information on PPARγ, visit the Nuclear Receptor Resource.
Synonyms: Peroxisome Proliferator-Activated Receptor Gamma, PPARγ, PPARg, PPAR gamma, Human Peroxisome Proliferator-Activated Receptor Gamma, hPPARγ, NR1C3
Also available in: Mouse/Rat Shared Ortholog, Cyn Monkey, Zebrafish
This Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) kit is an all-inclusive assay system that includes, in addition to PPARγ Reporter Cells, two optimized media for use during cell culture and (optionally) in diluting the test samples, a reference agonist, Luciferase Detection Reagent, a cell culture-ready assay plate, and a detailed protocol.
PPARγ Reporter Cells are prepared using INDIGO’s proprietary CryoMite™ process. This cryo-preservation method yields high cell viability post-thaw, and provides the convenience of immediately dispensing healthy, division-competent reporter cells into assay plates. There is no need for intermediate spin-and-wash steps, viability determinations, or cell titer adjustments.
This kit product is an all-inclusive assay system that includes, in addition to PPARγ Reporter Cells, two optimized media for use during cell culture and (optionally) in diluting the test samples, a reference agonist, Luciferase Detection Reagent, a cell culture-ready assay plate, and a detailed protocol.
Kits are offered in different assay formats to accommodate researchers’ needs: 3x 32, 1x 96, and 1x 384 assay formats for screening small numbers of test compounds, as well as custom bulk reagents for HTS applications.
Bulk assay reagents can be custom manufactured to accommodate any scale of HTS. Please inquire.
Service Assays: Human, Rat/Mouse Shared Ortholog, Cyn Monkey, Zebrafish
The primary application of INDIGO’s cell-based nuclear receptor assays are to quantitatively assess the bioactivity of a test compound as an agonist (activator) or antagonist (inhibition of an agonist response) of a given receptor. Service assays include a positive control reference compound and ‘vehicle’ control for every experiment. A formal study report and all data files are provided to the client upon completion of the study. To receive a quote for your proposed study, complete & submit the online “Request a Quote” form or contact an INDIGO Customer Service Representative to discuss your desired study parameters.